September 21, 2016
1 min read
Save

Study: More targeted early RA interventions needed

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

For patients, returning to a normal life is the most important outcome in early rheumatoid arthritis.

In this longitudinal, qualitative study, researchers individually interviewed 26 patients with early rheumatoid arthritis (RA) 4 months to 6 months after the start of their first treatment. Fourteen patients participated in one of three focus groups that occurred at least 1 year after the beginning of treatment. This study was part of the Care for early RA (CareRA) trial, a prospective, 2-year, multicenter, randomized controlled trial.

In both interviews, the patients’ desired outcome of returning to normal was related to four critical areas: disease control aspects; physical aspects; participation aspects; and mental aspects. During the first interview, the patients were more focused on pain relief, medication side effects and burden, and emotional well-being, the authors wrote. With time, the patients’ view of normal changed, becoming more realistic; however, pain relief remained a primary desired outcome.  

These results underscore the need for more targeted and holistic therapeutic interventions in early RA, the authors wrote. More research is needed to determine whether patient-preferred outcomes should be considered in early RA management. by Colleen Owens

 

Disclosure: The researchers report no relevant financial disclosures.